Our study showed that s-APEX1 levels in the HCC, CC, and ccRCC groups were statistically sufficient diagnostic accuracy to distinguish the caner groups from both the healthy control group and the HBV DNA (+) group. Here, APEX1 is linked to cholangiocarcinoma.